As shown in Figure 1D, these results consistently showed that the expression of YAP1 in pancreatic cancer, glioma, ovarian cancer, and colorectal cancer were significantly higher than the corresponding normal tissues. This evidence concerns the gene YAP1 and central nervous system cancer.